HRP20131170T1 - Nova antibakterijska sredstva za lijeäśenje gram-pozitivnih infekcija - Google Patents

Nova antibakterijska sredstva za lijeäśenje gram-pozitivnih infekcija Download PDF

Info

Publication number
HRP20131170T1
HRP20131170T1 HRP20131170AT HRP20131170T HRP20131170T1 HR P20131170 T1 HRP20131170 T1 HR P20131170T1 HR P20131170A T HRP20131170A T HR P20131170AT HR P20131170 T HRP20131170 T HR P20131170T HR P20131170 T1 HRP20131170 T1 HR P20131170T1
Authority
HR
Croatia
Prior art keywords
pharmaceutical preparation
intended
bacteria
resistant
accordance
Prior art date
Application number
HRP20131170AT
Other languages
English (en)
Croatian (hr)
Inventor
Andre Lee Pearson
Chester A. Metcalf Iii
Jing Li
Original Assignee
Cubist Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharmaceuticals, Inc. filed Critical Cubist Pharmaceuticals, Inc.
Publication of HRP20131170T1 publication Critical patent/HRP20131170T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP20131170AT 2008-12-22 2009-12-18 Nova antibakterijska sredstva za lijeäśenje gram-pozitivnih infekcija HRP20131170T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13987508P 2008-12-22 2008-12-22
PCT/US2009/068747 WO2010075215A1 (en) 2008-12-22 2009-12-18 Novel antibacterial agents for the treatment of gram positive infections

Publications (1)

Publication Number Publication Date
HRP20131170T1 true HRP20131170T1 (hr) 2014-01-03

Family

ID=41718893

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20131170AT HRP20131170T1 (hr) 2008-12-22 2009-12-18 Nova antibakterijska sredstva za lijeäśenje gram-pozitivnih infekcija

Country Status (26)

Country Link
US (3) US8507647B2 (https=)
EP (2) EP2379580B1 (https=)
JP (1) JP5670914B2 (https=)
KR (1) KR101717795B1 (https=)
CN (1) CN102325787B (https=)
AR (1) AR074833A1 (https=)
AU (1) AU2009330245C1 (https=)
BR (1) BRPI0923567A2 (https=)
CA (1) CA2747965C (https=)
CY (1) CY1114883T1 (https=)
DK (1) DK2379580T3 (https=)
ES (1) ES2442167T3 (https=)
HR (1) HRP20131170T1 (https=)
IL (1) IL213638A0 (https=)
MX (1) MX2011006803A (https=)
NZ (1) NZ594019A (https=)
PL (1) PL2379580T3 (https=)
PT (1) PT2379580E (https=)
RS (1) RS53152B (https=)
RU (1) RU2512396C2 (https=)
SG (1) SG172299A1 (https=)
SI (1) SI2379580T1 (https=)
SM (1) SMT201400037B (https=)
TW (1) TWI444198B (https=)
WO (1) WO2010075215A1 (https=)
ZA (1) ZA201104693B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013157188A (ru) * 2011-05-26 2015-07-10 Кьюбист Фармасьютикалз, Инк. Композиции св-183,315 и относящиеся к ним способы
US10377699B2 (en) * 2013-11-06 2019-08-13 The University Of Hong Kong Daptomycin analogues and a method for the preparation of daptomycin or a daptomycin analogue
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
US11667674B2 (en) * 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
ES2791319T3 (es) * 2016-04-22 2020-11-03 Astrazeneca Ab Inhibidores de MCL1 macrocíclicos para tratar el cáncer
US10098890B2 (en) 2016-10-29 2018-10-16 Cipla Limited Stable carfilzomib formulations
IT201600127655A1 (it) * 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
EP0087953B1 (en) 1982-02-27 1988-04-27 Beecham Group Plc Antibacterial 1-normon-2-yl-heterocyclic compounds
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) * 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
SU1452484A3 (ru) 1984-10-09 1989-01-15 Эли Лилли Энд Компани (Фирма) Способ получени производных антибиотиков А-21978С, штамм стрептомицета SтRертомYсеS RoSeoSpoRUS, используемый дл получени антибиотических веществ А-21978С
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US5039660A (en) 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
ES2089133T3 (es) * 1990-06-07 1996-10-01 Lilly Co Eli Desacilasa de lipopeptidos.
AU7497594A (en) 1993-08-13 1995-03-14 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69739532D1 (de) 1996-03-08 2009-09-24 Astellas Pharma Inc Prozess für die deacylierung von zyklischen lipopeptiden.
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
PL203689B1 (pl) 1998-09-25 2009-11-30 Cubist Pharmaceuticals Zastosowanie daptomycyny
EP1279057B1 (en) 1999-11-03 2013-03-20 The Whitaker LLC Optoelectric module for multi-fiber arrays
MXPA02006028A (es) 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos novedosos como agentes antibacterianos.
WO2001044274A1 (en) 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
CN1425025A (zh) 1999-12-15 2003-06-18 卡比斯特制药公司 作为抗菌剂的新颖的脂肽
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
RU2348647C2 (ru) 2001-08-06 2009-03-10 Кьюбист Фармасьютикалз, Инк Новые депсипептиды и способы их получения
WO2006110185A2 (en) 2004-11-12 2006-10-19 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides

Also Published As

Publication number Publication date
US8507647B2 (en) 2013-08-13
CA2747965A1 (en) 2010-07-01
RU2011130278A (ru) 2013-01-27
AR074833A1 (es) 2011-02-16
RU2512396C2 (ru) 2014-04-10
EP2674437A1 (en) 2013-12-18
SG172299A1 (en) 2011-07-28
EP2379580B1 (en) 2013-10-23
RS53152B (sr) 2014-06-30
AU2009330245A1 (en) 2011-08-04
KR101717795B1 (ko) 2017-03-17
JP2012513467A (ja) 2012-06-14
WO2010075215A1 (en) 2010-07-01
TWI444198B (zh) 2014-07-11
NZ594019A (en) 2013-08-30
HK1161886A1 (en) 2012-08-10
KR20110114592A (ko) 2011-10-19
BRPI0923567A2 (pt) 2016-09-27
SMT201400037B (it) 2014-05-07
US20140073558A1 (en) 2014-03-13
US20150337013A1 (en) 2015-11-26
JP5670914B2 (ja) 2015-02-18
CY1114883T1 (el) 2016-12-14
EP2379580A1 (en) 2011-10-26
ZA201104693B (en) 2013-01-30
CN102325787B (zh) 2014-05-28
CN102325787A (zh) 2012-01-18
PL2379580T3 (pl) 2014-05-30
MX2011006803A (es) 2011-09-06
DK2379580T3 (da) 2014-01-20
US20100184649A1 (en) 2010-07-22
SI2379580T1 (sl) 2014-02-28
PT2379580E (pt) 2014-01-20
IL213638A0 (en) 2011-07-31
ES2442167T3 (es) 2014-02-10
TW201028161A (en) 2010-08-01
AU2009330245B2 (en) 2013-05-02
CA2747965C (en) 2017-06-27
AU2009330245C1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
HRP20131170T1 (hr) Nova antibakterijska sredstva za lijeäśenje gram-pozitivnih infekcija
JP2012513467A5 (https=)
JP2022058682A5 (https=)
ES2856831T3 (es) Una composición que comprende un antibiótico no peptídico y cisteamina
RU2020133461A (ru) Предотвращение, разрушение и обработка биопленки лизином бактериофага
del Prado et al. Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin
RU2018107249A (ru) Применение лизина для восстановления/увеличения антибактериальной активности антибиотиков в присутствии легочного сурфактанта, который ингибирует указанные антибиотики
HRP20130928T1 (hr) C7-fluor supstituirani spojevi tetraciklina
DK1506214T3 (da) 6-11 bicykliske ketolidderivater
EA201101319A1 (ru) Композиции и способы элиминации грамотрицательных бактерий
CN101175531A (zh) 包含一种抗菌药以及一种选自香芹醇、麝香草酚、丁香酚、冰片、香芹酚的活性物质的药物组合物
Fan et al. Antibacterial activity of the recombinant antimicrobial peptide Ib-AMP4 from Impatiens balsamina and its synergy with other antimicrobial agents against drug resistant bacteria
JP2017519730A5 (https=)
Zhou et al. Potential of berberine to enhance antimicrobial activity of commonly used antibiotics for dairy cow mastitis caused by multiple drug-resistant Staphylococcus epidermidis infection
MX2007007235A (es) Combinacion de antibioticos para proporcionar una solucion total al tratamiento de infecciones.
RU2015134149A (ru) Композиции и способы лечения бактериальных инфекций
RU2004118716A (ru) Лечение инфекции, вызываемой микроорганизмами
WO2005070945A8 (ja) メチシリン耐性黄色ブドウ球菌（ｍｒｓａ）に有効な新規アミノグリコシド系抗生物質
JP2017533177A5 (https=)
TW200510541A (en) Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
JP2018504434A (ja) オーラノフィンを使用してバイオフィルムを抑制及び分散する方法
CN108420814A (zh) 一种nps-2143用于抗菌的新用途
EA200701384A1 (ru) Антибиотик 107891, его факторы a1 и a2, фармацевтически приемлемые соли и композиции и их применение
WO2009124086A3 (en) Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections
Nagy et al. In vitro activity of daptomycin-metronidazole combinations against mixed bacterial cultures: reduced activity of metronidazole against Bacteroides species in the presence of Enterococcus faecalis